Preprint · OA
via OpenAlex
The identification and analysis of molecular biomarkers in the p53 tumour suppressor pathway that affect cancer progression in humans
Anna M. Grawenda, Grawenda, Anna M
Oxford University Research Archive (ORA) (University of Oxford) · 2013
Abstract
The tumour suppressor p53 is at the centre of the signalling pathway that controls cellular processes crucial in tumourogenesis, cancer progression and tumour clearance. Alterations in the p53 pathway that lead to cancer progression can be good candidates for molecular biomarkers that would assist in the identification of patients with different prognoses, but also serve as good predictors of appropriate targeted therapies. Patient cohorts and cancer cell panels are utilised to seek associations with the attenuation of the p53 pathway and cancer progression. Firstly, the alternatively spliced transcript of the p53 inhibitor HDMX, which is frequently found in tumours with poor prognosis, is studied. The high ratio of the alternatively spliced HDMX-S transcript over the full-length HDMX-FL transcript (HDMX-S/FL) is demonstrated to associate with p53 pathway attenuation in cancer cells and breast carcinomas, and with faster metastatic progression of osteosarcoma and breast cancer patients. Secondly, inherited polymorphism in the HDMX gene is investigated and demonstrated as a unique and highly reproducible eQTL, which identifies patients with different prognoses for metastatic disease in breast cancer and melanoma cohorts. Lastly, a screening approach to identify novel inherited polymorphisms in the p53 pathway genes that associate with metastatic progression of melanoma is developed and implemented, and subsequently in silico and in vitro functional analyses are performed to investigate a mechanism behind the FOXO3 SNP, identified as the strongest candidate, whereby the experimental evidence demonstrate that the causal SNP in the FOXO3 haplotype is controlled by the GATA3 transcription factor. Together, the work presented in this thesis provides strong support for the role of the p53 pathway in the metastatic progression of cancer, and suggests that molecular biomarkers that can detect changes in the activity of p53 pathway genes could offer a robust set of biomarkers for cancer progression applicable to different types of cancer.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.5287/ora-ovrbb8e1y
- Canonical
- link ↗
- Fetched
- 2026-10-23 MST
Cite this
APA
Grawenda, A.M., & M, G.A. (2013). The identification and analysis of molecular biomarkers in the p53 tumour suppressor pathway that affect cancer progression in humans. <em>Oxford University Research Archive (ORA) (University of Oxford)</em>. https://doi.org/10.5287/ora-ovrbb8e1y
Vancouver
Grawenda AM, M GA. The identification and analysis of molecular biomarkers in the p53 tumour suppressor pathway that affect cancer progression in humans. Oxford University Research Archive (ORA) (University of Oxford). 2013. doi:10.5287/ora-ovrbb8e1y.
BibTeX
@unpublished{anna2013Theide,
title = {The identification and analysis of molecular biomarkers in the p53 tumour suppressor pathway that affect cancer progression in humans},
author = {Anna M. Grawenda and Grawenda, Anna M},
journal = {Oxford University Research Archive (ORA) (University of Oxford)},
year = {2013},
doi = {10.5287/ora-ovrbb8e1y},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature Communications 2022
Open access · CC-BY
Distinctive molecular features of regenerative stem cells in the damaged male germline
Aging and disease 2026
Citation only
Senescence and SASP in the Stromal Microenvironment of Breast Cancer: Dual Role in Progression and Therapeutic Options.
The Journal of Pathology 2010
Open access · OA
Cancer stem cells: problems for therapy?
Frontiers in Nutrition 2025
Open access · CC-BY
Polyphenols and exercise in autophagy regulation: potential benefits for cancer management and healthspan
International Journal of Oncology 2006
Open access · OA
Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro
International Journal of Cancer 2010
Open access · OA